Joshua S. Jacobs

基本信息

Career Trajectory

Bio

Dr. Jacob’s areas of interest are the treatment of hereditary angioedema, chronic sinusitis, atopic dermatitis/food allergy, asthma and primary immunodeficiency.

Research Interests

Papers共 58 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Garadacimab for Hereditary Angioedema Prophylaxis in Adolescents: Efficacy and Safety from the Phase 3 (VANGUARD) Study and Open-Label Extension (second Interim Analysis)

Joshua Jacobs,Markus Magerl,Inmaculada Martinez-Saguer,Huamin Li,Jonathan Bernstein,Connie Hsu,Karl Sitz,Lolis Wieman,Henrike Feuer-Senger, Maressa Pollen,Avner Reshef

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYno. 2 (2024): AB6-AB6

Cited0Views0Bibtex

The Utility of Shared Decision Making in the Management of Hereditary Angioedema

Rachel Odin,John Anderson,Joshua Jacobs, Douglas Jones,H. Henry Li,William Lumry,Michael Manning,Daniel Soteres,Raffi Tachdjian,William Yang,Jonathan A. Bernstein

ALLERGY AND ASTHMA PROCEEDINGSno. 6 (2024): 434-437

Cited0Views0WOSBibtex

Integrated Safety and Efficacy of Garadacimab for Hereditary Angioedema Prophylaxis Across 3 Clinical Trials: Phase 2, Pivotal Phase 3, and Open-Label Extension Studies

M. Magerl,T. J. Craig,J. Anderson,J. S. Jacobs,R. Tachdjian,H. Farkas,W. H. Yang, P. Staubach,E. Aygoeren-Puersuen,I. Ohsawa, M. Pollen,J. -P. Lawo, M. A. Bica,I. Jacobs

ALLERGOLOGIEno. 9 (2024)

Cited0Views0Bibtex

REMIBRUTINIB PROVIDES FAST AND CLINICALLY IMPORTANT IMPROVEMENT OF CHRONIC SPONTANEOUS URTICARIA DISEASE ACTIVITY

J. Jacobs, M. Maurer,A. Gimenez-Arnau,S. Savic,C. Ortmann, B. Suryawanshi,I. Nikolaev,S. Haemmerle

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGYno. 5 (2023): S34-S35

Cited0Views0Bibtex

Approach to Identification of Patients with Activated Phosphoinositide-3 Kinase Delta Syndrome (APDS)

Daniel Suez,Richard Wasserman,Amy Darter,Elena Perez,Joshua Jacobs,Dareen Siri, David Patterson, Jacob Offenberger,William Lumry,Mark Scarupa

Journal of Allergy and Clinical Immunologyno. 2 (2023): AB81-AB81

Cited0Views0Bibtex

Tezepelumab Efficacy by SNOT-22 Score in Patients with Severe, Uncontrolled Asthma and Comorbid Nasal Polyps in NAVIGATOR

Joshua Jacobs,Flavia Hoyte,Joseph Spahn,Chris Ambrose,Nicole Martin, Sylvia Vong,Scott Caveney,Bill Cook,Gene Colice

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY（2023）

Cited2Views0Bibtex

Efficacy and Safety of Lanadelumab in Pediatric Patients with Hereditary Angioedema Aged 2 to < 12 Years: Results of the Open-Label, Multi-Centric Phase 3 SPRING Study

M. Kappek,M. Maurer,W. R. Lumry,H. H. Li, E. Aygoeren-Pursun,P. Busse,J. Jacobs,C. Nurse

ALLERGOLOGIE（2023）

Cited0Views0Bibtex

Maureen Watt,Marcus Maurer,William Lumry,H. Henry Li,Emel Aygoeren-Puersuen,Paula Busse,Joshua Jacobs,Christina Nurse,Ming Yu,Dorothy Romanus,Giovanna Devercelli

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYno. 2 (2023): AB139-AB139

Cited1Views0Bibtex

LONG-TERM SAFETY AND EFFICACY WITH GARADACIMAB FOR HEREDITARY ANGIOEDEMA PROPHYLAXIS IN AN OPEN-LABEL EXTENSION STUDY

J. Anderson,D. Levy,G. Sussman,J. Jacobs,H. Farkas,M. Pollen,H. Feuersenger,T. Craig

Annals of Allergy, Asthma &amp Immunologyno. 5 (2023)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Medical Director

Papers共 58 篇Author StatisticsCo-AuthorSimilar Experts